A unique collection of 515 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); Bioactivity and safety confirmed by pre-clinical research and clinical trials and most of them are approved by FDA, EMA, or CFDA; Covers various major targets including membrane transporter, ion channel, etc.; Effect tool for research in cardiovascular disease. Detailed compound information with structure, target, activity, IC50 value, and biological activity description; Structurally diverse, medicinally active, and cell permeable; NMR and HPLC validated to ensure high purity and quality
